Introduction
============

Early coagulation support is essential in massively bleeding patients. A Coagulation Support Algorithm (CSA), integrating rapid TEG (r-TEG) and functional fibrinogen TEG (ff-TEG) could shorten the time to a tailored treatment (Figure [1](#F1){ref-type="fig"}).

![**Coagulation Support Algorithm**.](cc14432-1){#F1}

Methods
=======

A retrospective comparison of the time to available TEG and Standard Coagulation Tests (SCT: INR, aPTTr, fibrinogen level) results in two groups of bleeding and coagulopathic patients using citrate kaolin-TEG (k-TEG) or the CSA protocol (r-TEG/ff-TEG). Statistical analysis was performed with Student\'s *t*test for unpaired samples.

Results
=======

Twenty-three patients for each k-TEG and CSA group were compared. The time to available results was shorter using the CSA protocol in comparison with k-TEG (Table [1](#T1){ref-type="table"}). The differences were both statistically (*P*\< 0.00001) and clinically (mean reduction time 21 minutes) significant. SCT needed the longest time to obtain the final results.

###### 

Comparison of time to results.

  Test             k-TEG         r-TEG           r-TEG + ff-TEF   SCT
  ---------------- ------------- --------------- ---------------- --------------
  r (minutes)      13.8 ± 7.1    2.6 ± 2         \-               
  ACT (seconds)                  265.7 ± 171.9   \-               105.2 ± 46.3
  TMA (minutes)    42.6 ± 12.4   25.4 ± 14.1     \-               
  CSAT (minutes)                                 21 ± 7.4         

Data presented as mean ± SD. ACT, activated clotting time; CSAT, Coagulation Support Algorithm total time; SCT, standard coagulation tests; TMA, time to maximum amplitude. r: r-TEG versus k-TEG, *P =*0.0000003; r-TEG versus SCT, *P =*0.000000001; k-TEG versus SCT, *P =*0.000000009; TMA: r-TEG versus k-TEG, *P =*0.0001; r-TEG versus SCT, *P =*0.00000004; k-TEG versus SCT, *P =*0.000002; ACT versus r of k-TEG (seconds), *P =*0.000004; CSAT versus k-TMA, *P =*0.00000005.

Conclusion
==========

The implementation of a CSA, including r-TEG and ff-TEG, could shorten the time to a targeted treatment in critically bleeding patients.
